|
Volumn 332, Issue 7555, 2006, Pages 1439-
|
Pharmacological management—inhaled treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
BUDESONIDE;
BUDESONIDE PLUS FORMOTEROL;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
FLUTICASONE PROPIONATE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
IPRATROPIUM BROMIDE;
IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;
LONG ACTING DRUG;
OXITROPIUM BROMIDE;
SALBUTAMOL;
SHORT ACTING DRUG;
TIOTROPIUM BROMIDE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
ACUTE ANGLE GLAUCOMA;
AIRWAY OBSTRUCTION;
BLADDER OBSTRUCTION;
BRONCHODILATATION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONSTIPATION;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG EFFICACY;
EXERCISE TOLERANCE;
GLAUCOMA;
HEADACHE;
HUMAN;
HYPOKALEMIA;
INHALER;
MUSCLE CRAMP;
NAUSEA;
NERVOUSNESS;
PRESCRIPTION;
PRIORITY JOURNAL;
QT PROLONGATION;
SHORT SURVEY;
SIDE EFFECT;
SYMPTOMATOLOGY;
TACHYCARDIA;
TREMOR;
XEROSTOMIA;
DELAYED RELEASE FORMULATION;
DRUG COMBINATION;
INHALATIONAL DRUG ADMINISTRATION;
NEBULIZER;
REVIEW;
ADMINISTRATION, INHALATION;
ADRENAL CORTEX HORMONES;
ADRENERGIC BETA-AGONISTS;
BRONCHODILATOR AGENTS;
CHOLINERGIC ANTAGONISTS;
DELAYED-ACTION PREPARATIONS;
DRUG COMBINATIONS;
HUMANS;
NEBULIZERS AND VAPORIZERS;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
|
EID: 33745313743
PISSN: 09598138
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.332.7555.1439 Document Type: Article |
Times cited : (6)
|
References (0)
|